Global study sees India having edge in vaccines
NEW DELHI, Nov. 2 -- India has used its manufacturing capability to pre-order 600 million doses of the Covid-19 vaccine and is negotiating for another billion doses, enough to vaccinate at least half the population, according to a new global analysis of advance market commitments for experimental vaccines till October 8. Most experimental Covid-19 vaccines require two doses....
To read the full article or to get the complete feed from this publication, please
Contact Us.